Journal of Cell Science & Therapy
Open Access
ISSN: 2157-7013
+44 1300 500008
ISSN: 2157-7013
+44 1300 500008
Department of Pharmacology, University of Gondar, College of Medicine and Health Sciences, School of Pharmacy, Gondar, Ethiopia
Zemene Demelash Kifle: He worked on Pharmacology at the University of Gondar.Department of Pharmacology, University of Gondar, College of Medicine and Health Sciences, School of Pharmacy, Gondar, Ethiopia
Subjects of Specialization: Infection, Toxicology, In vitro and in vivo antidiabetic activities, Wound healing activity, Cross-sectional study, Antimalarial,Antioxidant Assays, Health Care Peer Review, Diabetes, Clinical Research
Review Article
The Latest Information on Antiviral Therapy, Immunotherapy and Cell Therapy for COVID-19
Author(s): Zemene Demelash Kifle* and Engidaw Fentahun Enyew
The cases of COVID-19 have been found in many countries around the world. Corona virus disease 2019
(COVID-19), being an emerging infectious disease, is a serious threat to human health. Current clinical management
includes infection prevention and control measures and supportive care including supplemental oxygen and
mechanical ventilatory support. Evolving research and clinical data regarding the virologic SARS-CoV-2 suggest a
potential list of repurposed drugs with appropriate pharmacological effects and therapeutic efficacies in treating
COVID-19 patients. The structure of the SARS-CoV-2 virus comprises of S proteins, M proteins, E proteins,
hemagglutinin esterases, nucleocapsid proteins, and RNA genome. Viral proteases cleave these polyproteins and
RNA-dependent polymerases replicate the genome. Numerous investigators are developing novel protease inhibitors,.. View More»
DOI:
10.35248/2157-7013.21.12.303